openPR Logo
Press release

Blood Plasma Derivatives Market Projected to Grow at a Steady Pace During 2027

01-14-2022 09:46 AM CET | Health & Medicine

Press release from: market research future

Blood Plasma Derivatives Market

Blood Plasma Derivatives Market

Global Blood Plasma Derivatives Market - Overview
The global blood plasma derivatives market is growing mainly due to the increasing demand for plasma derived products. According to a recent study report published by the Market Research Future, The global blood plasma derivatives market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Plasma is a fluid part of the blood that contains blood cells, and protein responsible for blood clotting. Plasma derivatives are obtained from specific plasma proteins by the process of fractionation. The derivatives are then solvent detergent-treated or heat-treated to kill certain viruses. The most common plasma derivative includes factor IX concentrate, factor VIII concentrate, anti-inhibitor coagulation complex (AICC), anti-thrombin III concentrate, immune globulins, Alpha 1-Proteinase inhibitor concentrate, albumin, and anti-thrombin III concentrate. Blood plasma derivative widely used clinically to treat various conditions such as hemophilia A, hemophilia B, HIV, hepatitis B, hepatitis C, thrombocytosis, and others.
Notably, rising demand for plasma derivative based therapies is the key factor driving the blood plasma derivatives market. According to a study published in the Journal of Blood Medicine in 2016, it is found that FIX replacement therapy which includes plasma-derived protein are successful in the reduction of disability, and bleeding from hemophilia B. Based on the prevalence rate, hemophilia and von willebrand disease (VWD) are the most common bleeding disorders in the Middle East and Africa. According to the 2014 Annual Global Survey of World Federation of Hemophilia (WFH), in 2014 the total population of Egypt was 86,895,099 out of which 5,246 people were living with hemophilia, 513 were living with von willebrand disease, and 1,123 with other bleeding disorders. It is also reported that 4201 cases of hemophilia A were registered and among them 37% were under 4 years.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1325

Other factors such as, rising incidence of hemophilia, huge funding for research & development, technological advancements, and rising approval from regulatory bodies are also fuelling the market growth. According to the Centers for Disease Control and Prevention, it is found that Hemophilia A affects 1 in 5,000 male births i.e. around 400 babies are born with hemophilia A every year.
Despite these drivers, stringent reimbursement policies, safety concerns, and high cost of treatment is expected to decline the blood plasma derivatives market growth.

Global Blood Plasma Derivatives Market - Competitive Analysis
Grigols (Spain), Baxter International Inc. (US), Octapharma AG (Switzerland), CSL Limited (Australia), Kedrion S.p.A (Italy), Bain Capital, LLC (US), Biotest AG (Germany), Fusion Healthcare (India), SK Plasma Co., Ltd. (South Korea) are some of the prominent players at the forefront of competition in the blood plasma derivatives market and are profiled in MRFR Analysis.
The global blood plasma derivatives market is currently dominated by few players.
Grigols is one of them by holding a strong share in the market. The company’s stronghold is largely attributed to its innovative and sustainable products. Grigols aoperates in three major divisions i.e. Bioscience, Diagnostic and Hospital. On November 17, 2017 Grigols received FDA approval for a new genetic test used to detect alpha-1 antitrypsin deficiency. On November 11, 2013, Grifols acquired blood transfusion testing unit of Novartis AG for USD 1.68 billion. In the year 2016, Grifols has also acquired NAT (Nucleic Acid Testing) donor screening unit of Hologic for USD 1,850 million.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market-1325

Baxter is also one of the leading player in blood plasma derivatives market. Baxter International Inc., the US based biopharmaceutical company, operates in two major segments, i.e. Hospital Products and Renal. Baxter’s product Bebulin (Factor IX Complex) is specifically used for the prevention, of hemorrhagic episodes in case of hemophilia B. Bebulin may carry a risk of transmitting infectious agents, such as viruses and, Creutzfeldt‐Jakob disease (CJD) agent.
On July 27, 2017, Baxter International Inc. completed the acquisition of Claris Injectables Limited for approximately USD 625 million. The main motive of acquisition is the expansion of generic pharmaceuticals.

On June 06, 2017, ADMA Biologics, Inc., a biopharmaceutical company, has acquired therapy business unit of Biotest Pharmaceuticals. As a result of this, ADMA acquired two FDA approved products i.e. Nabi-HB™, and and BIVIGAM™.

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blood Plasma Derivatives Market Projected to Grow at a Steady Pace During 2027 here

News-ID: 2527053 • Views: 85

More Releases from market research future

Corporate Wellness Market Research Report, Industry Growth, Business Share, Size …
Market Highlights: The Global Corporate Wellness Market will reach value of USD 93.0 Billion in 2028 and is projected to grow at a CAGR of 7.0% over the forecast period. Corporate wellness programs are health promotion activities designed & conducted by corporate employers to support employees to understand their health risks, pursue healthy behavior at the workplace, and decrease the expenditure on healthcare. Currently, these programs are increasingly conducted by corporates
Facial Injectors Market Research Report, Industry Growth, Business Share, Size, …
Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – till 2027 Market Scenario Market Research Future (MRFR) speculates that the Global Facial Injectors Market is predicted to
Healthcare Cold Chain Logistics Market Global Demand, Stock, Strategy, Size, Bus …
Healthcare Cold Chain Logistics Market Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2027 Healthcare Cold Chain Logistics Market – Overview The progress in the pharmaceutical sector has amplified the reliance
Ophthalmic Drugs Market Research Report, Industry Growth, Business Share, Size, …
“Global Ophthalmic Drugs Market” Report of Market Research Future (MRFR)’s Explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Major Drivers, Restraints, Opportunities and Challenges. Market Scenario A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are

All 5 Releases


More Releases for Plasma

Bovine Blood Plasma Derivatives
Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Platelet, Plasma Market
Platelet, Plasma Market is estimated to surpass $ 6.3 Billion markets in 2019 and reach USD 14.56 Billion by 2024, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period 2016-2024 globally. For More Information Visit https://www.maximizemarketresearch.com/market-report/platelet-plasma-market/11293/ A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According
Global Blood Plasma Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia,
Cold Plasma Technology Market Size
This report focuses on the global Cold Plasma Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cold Plasma Technology development in United States, Europe and China. In 2017, the global Cold Plasma Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. Download FREE Sample of
Plasma Light Market: Pure Plasma Lighting, Lightahead, CozyCabin, RioRand, Cryst …
MarketResearchReports.Biz adds “Global Plasma Light Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Plasma Light market and the growth estimates for the forecasted period. This report studies the global Plasma Light market status and forecast, categorizes the global Plasma Light market size (value & volume) by key players, type, application, and region. This report focuses on the top
Plasma Equipment Market Trend to 2025 Profiling Plasma Air, Plasma etching techn …
The Plasma Equipment Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the Plasma Equipment industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. In this report, the global Plasma Equipment market value is provided for 2017 in million-dollar terms